Papers
1
Total Citations
2
H-Index
1
About
Lin Ye is a leading surgical oncologist whose research focuses on optimizing treatment strategies for hepatocellular carcinoma (HCC), with particular emphasis on comparing minimally invasive and open surgical approaches. Her landmark nationwide cohort study, published in 2025, systematically evaluated clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection for BCLC 0/A HCC patients. This work has already garnered significant attention with 2 citations in its first year, highlighting its immediate impact on surgical decision-making. Ye's major contribution lies in providing robust, population-level evidence that helps surgeons and patients navigate the complex trade-offs between surgical approaches—balancing oncologic efficacy, recovery times, and healthcare costs. Her research addresses a critical gap in hepatobiliary surgery, where debates about optimal techniques have persisted without clear comparative data. By leveraging nationwide datasets, Ye's work offers generalizable insights that transcend single-institution experiences. Her findings are particularly valuable for guiding treatment protocols in early-stage HCC, where surgical approach can significantly influence both short-term outcomes and long-term survival. Ye continues to advance the field through rigorous comparative effectiveness research that directly informs clinical practice.
Research Focus
Key Achievements
Top Papers
- 1